Fatty liver / MASLD
Can omega-3s improve fatty liver disease?
Some studies suggest improvements in liver fat or selected enzymes. Evidence that omega-3s reverse fibrosis or prevent liver-related clinical events is not established by those changes.
Updated September 24, 2026 · Editorial attribution: PV Griscom, M.Sc. · Independent clinical review pending
The question behind the headline
Adults studied under the older NAFLD terminology; studies assessed imaging and laboratory measures.
What the finding does—and doesn’t—tell us
A 2025 review reported substantial heterogeneity and few ultrasound studies. Liver fat, inflammation and fibrosis should not be treated as equivalent.
Read the underlying research.
Selected sources, not an exhaustive reference list. Research record or abstract screening only; full-text efficacy appraisal is pending. Source publication dates may precede this page’s update date.
Three questions to take forward
- Was the study population similar to the person or situation I have in mind?
- Did it measure an outcome people feel or experience, or only a laboratory marker?
- How do formulation, usual care, absolute benefit and adverse effects change the interpretation?
Study doses describe experiments; they are not personal dosing advice. Explore safety and limitations ↗